The Role of Connexins in Carcinogenesis: Review of Current Knowledge
Journal:
Current Signal Transduction Therapy
Volume:
2
Page:
49-56
Author(s):
Kanczuga-koda Luiza, Sulkowski Stanislaw, Koda Mariusz, Wincewicz Andrzej, Rutkowski Tadeusz and Moniuszko Mariola
Therapeutic Transfer of DNA Encoding Adenoviral E1A
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
1-10
Author(s):
Helmut Deissler and Bertram Opalka
Ribonucleotide Reductase: A Critical Enzyme for Cancer Chemotherapy and Antiviral Agents
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
11-29
Author(s):
S. A. Nuno M. F. S. A. Cerqueira, Pedro A. Fernandes and Maria J. Ramos
Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
59-71
Author(s):
Anand Veeravagu, Andrew R. Hsu, Weibo Cai, Lewis C. Hou, Victor C.K. Tse and Xiaoyuan Chen
New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
73-78
Author(s):
Floriana Facchetti, Elena Monzani and Caterina A.M. La Porta
Patent Annotations
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
103-105
Author(s):
Bentham Science Publisher
Subject Index To Volume 1
Journal:
Recent Patents on Anti-Cancer Drug Discovery
Volume:
2
Page:
vi-vi
Author(s):
Bentham Science Publisher
ABCB1, SLCO1B1 and UGT1A1 Gene Polymorphisms Are Associated with Toxicity Line Irinotecan
Journal:
Drug Metabolism Letters
Volume:
1
Page:
23-30
Author(s):
Katrin E. Rhodes, Wu Zhang, Dongyun Yang, Oliver A. Press, Michael Gordon, Daniel Vallbohmer, Anne M. Schultheis, Georg Lurje, Robert D. Ladner, William Fazzone, Heinz-Josef Lenz and Syma Iqbal
The JAK-STAT Pathway: A Therapeutic Target in Hematological Malignancies
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
671-679
Author(s):
A. Ferrajoli, S. Faderl, F. Ravandi and Z. Estrov
EGFR-Targeting Monoclonal Antibodies in Head and Neck Cancer
Journal:
Current Cancer Drug Targets
Volume:
6
Page:
691-710
Author(s):
Igor Astsaturov, Roger B. Cohen and Paul M. Harari